Clinical Trials Browser

OTHER × Gestational Trophoblastic Disease × 1 year × Clear all

NCT03785574 2026-03-16

Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule

Phase NA Recruiting

Hydatidiform Mole, Gestational Trophoblastic Disease

NCT05139095 2026-02-05

Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia

Phase 2 Recruiting

Gestational Trophoblastic Disease

NCT07333326 2026-01-12

Uterine Artery Doppler Flow Velocimetry Parameters for Predicting the Occurrence of Persistent Gestational Trophoblastic Neoplasia After Evacuation of Complete Hydatiform Mole

Not yet recruiting

Gestational Trophoblastic Disease

NCT06790706 2025-10-06

IMMUNORARE5

Phase 2 Recruiting

EndocrineGastrointestinalGynecologicHead & NeckNETThoracic

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Thymoma, Gestational Trophoblastic Disease, Thyroid Carcinoma, Anaplastic

NCT04562558 2025-08-11

Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia

Phase NA Active not recruiting

Hydatidiform Mole, Invasive, Choriocarcinoma, Gestational Trophoblastic Disease

NCT06339827 2025-06-18

ASQ-GYO

Phase NA Recruiting

Uterine Cervical Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Gestational Trophoblastic Disease